Table A5.
Groups | Blood Glucose Concentration/(mmol/L) | ||||
---|---|---|---|---|---|
0 min | 30 min | 60 min | 120 min | AUC | |
NC | 4.49 ± 1.20 | 5.72 ± 0.93 | 5.31 ± 0.62 | 4.62 ± 0.54 | 7.79 ± 1.18 |
DC | 22.86 ± 2.74 ΔΔ | 31.27 ± 2.65 ΔΔ | 23.68 ± 2.77 ΔΔ | 23.22 ± 3.26 ΔΔ | 39.00 ± 3.52 ΔΔ |
ME | 15.78 ± 1.88 * | 22.62 ± 1.82 * | 20.59 ± 2.16 | 16.20 ± 2.00 * | 29.60 ± 2.26 ** |
LT | 18.85 ± 2.69 | 25.53 ± 2.72 | 23.64 ± 3.28 | 19.92 ± 2.56 | 34.27 ± 3.05 * |
MT | 17.53 ± 1.84 | 24.17 ± 2.21 * | 22.18 ± 2.09 | 18.67 ± 1.94 | 32.23 ± 2.74 ** |
HT | 17.68 ± 2.26 | 25.58 ± 3.14 | 21.91 ± 2.55 | 19.32 ± 2.91 | 32.99 ± 3.32 ** |
Note: (1) 0 min shows the blood glucose values before treatment; 30 min, 60 min, and 120 min show the blood glucose values at 30, 60, and 120 min of drug administration, respectively; (2) ΔΔ represents highly significant difference (p < 0.01) between DC group and NC group control. * Represents a significant difference (p < 0.05); ** represents a highly significant difference (p < 0.01) between the drug administration group and DC group.